Minerva Surgical, Inc. UTRS
At closeNov 2, 2026, 4:00 PM EST
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 887
- Revenue (ttm)
- 51.69M
- Profit margin
- -64.71%
- EPS (ttm)
- -7.49
- Shares out
- 8.88M
- Forward P/E
- -0.51
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 500
- Avg volume
- 25
- Open
- 0.0001
- Previous close
- 0.0001
- Day's range
- 0.0001 – 0.0001
- 52-week range
- 0.0001 – 0.001
- Beta
- 4.84
- Analysts
- Buy
- Earnings date
- Dec 23, 2024
2Y -0.0119 (-99.17%)
Key statistics
- Enterprise value
- 32.43M
- PEG ratio
- 0.00
- Price / sales
- 0.25
- Price / book
- 0.65
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -4.90%
- Free cash flow
- -18.49M
- Total cash
- 11.13M
- Total debt
- 43.55M
- Return on equity
- -160.07%
- Short % of float
- 3.70%
- 50-day average
- 0.00886
- 200-day average
- 0.72443
Analyst view
Consensus: buy
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Dec 23, 2024
Expected Dec 23, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Oct 2, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 2, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Nov 13, 2023 | Sep 1, 2023 | -1.00 | -0.81 | +0.19 | +19.00% |
| Aug 2, 2023 | Jun 1, 2023 | -1.80 | -1.00 | +0.80 | +44.44% |
About Minerva Surgical, Inc.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- minervasurgical.com
News
Financial Contrast: Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) vs. Minerva Surgical (NASDAQ:UTRS) 
INVO Fertility (NASDAQ:IVF) and Minerva Surgical (NASDAQ:UTRS) Head-To-Head Analysis 
T2 Biosystems (NASDAQ:TTOO) versus Minerva Surgical (NASDAQ:UTRS) Head-To-Head Review 
Head to Head Analysis: InspireMD (NYSE:NSPR) versus Minerva Surgical (NASDAQ:UTRS) 
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session - 12 Health Care Stocks Moving In Monday's Intraday Session
Why Is Minerva Surgical (UTRS) Stock Down 50% Today? - Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Minerva Surgical Reports Third Quarter 2023 Financial Results - Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Your note
Sign in to keep a note on UTRS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDERSON JILL | Director | Stock Award(Grant) | Jun 9, 2022 | 49,792 |
| BEHBAHANI ALI | Director | Stock Award(Grant) | Jun 9, 2022 | 58,279 |
| CLAPPER DAVID M | Chief Executive Officer | Stock Award(Grant) | May 1, 2022 | 965,892 |
| COSTE CATHERINE | Director | Stock Award(Grant) | Jun 9, 2022 | 129,579 |
| HUNT NIQUETTE L. | Director | Stock Award(Grant) | Jun 9, 2022 | 49,792 |
| JAFFE ROSS A. M.D. | Director | Stock Award(Grant) | Jun 9, 2022 | 1,818,250 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| NEA Management Company, LLC | 0.97% | 1,721,853 | 8.82M | Jun 29, 2023 |
| Versant Venture Management, LLC | 0.05% | 83,685 | 428.80K | Jun 29, 2023 |